<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Not all oxylipins have a detrimental effect on the heart. CYP enzymes are highly expressed in the heart, and they are involved in converting AA to eicosanoids, which have a cardio-protective role [
 <xref rid="B83-nutrients-11-01179" ref-type="bibr" class="xref">83</xref>,
 <xref rid="B84-nutrients-11-01179" ref-type="bibr" class="xref">84</xref>,
 <xref rid="B85-nutrients-11-01179" ref-type="bibr" class="xref">85</xref>]. Some of them, such as epoxy-eicosatrienoic acid (EpETrE), attenuate ischemia/reperfusion injury [
 <xref rid="B84-nutrients-11-01179" ref-type="bibr" class="xref">84</xref>]. Moreover, EpETrE improved the electrical activity of the heart following ischemia/reperfusion injury [
 <xref rid="B86-nutrients-11-01179" ref-type="bibr" class="xref">86</xref>,
 <xref rid="B87-nutrients-11-01179" ref-type="bibr" class="xref">87</xref>]. This protective role is induced through multiple pathways involving mitochondrial and sarcolemmal potassium channels, p42/p44 MAPK (mitogen-activated protein kinase), and PI3K-AKT [
 <xref rid="B88-nutrients-11-01179" ref-type="bibr" class="xref">88</xref>].
</p>
